Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,069Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 17Pfizer Australia Pty Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

tofacitinib

Brand Name : Xeljanz

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank